Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
Pharmacovigilance01:19

Pharmacovigilance

1.1K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K
Clinical Trials01:16

Clinical Trials

9.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A community-based rehabilitation package following hip fracture: FEMuR III a multi-centre RCT, economic and process evaluation.

Health technology assessment (Winchester, England)·2025
Same author

Effectiveness of a community-based rehabilitation programme following hip fracture: results from the Fracture in the Elderly Multidisciplinary Rehabilitation phase III (FEMuR III) randomised controlled trial.

BMJ open·2025
Same author

Effectiveness of a personalised self-management intervention for people living with long covid (Listen trial): pragmatic, multicentre, parallel group, randomised controlled trial.

BMJ medicine·2025
Same author

Assessing the Feasibility of Using Parents' Social Media Conversations to Inform Burn First Aid Interventions: Mixed Methods Study.

JMIR formative research·2024
Same author

Real-world occupational therapy interventions for early-stage dementia: Characteristics and contextual barriers.

Dementia (London, England)·2024
Same author

Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's disease.

BMJ open·2024
Same journal

Multimodule Human-Artificial Intelligence Collaboration Pipeline for Large Language Model-Assisted Thematic Analysis Across Digital Health Interview Studies: Comparative Evaluation Study.

JMIR medical informatics·2026
Same journal

Graph Network Feature Space Fusion for Predicting Irregularly Sampled Medical Time-Series Data: Deep Learning Model Development and Validation Study.

JMIR medical informatics·2026
Same journal

Intrasystem Repeatability of S-Detect for Breast Ultrasound Classification With Identical Static Images: Single-Center Retrospective Repeatability Study.

JMIR medical informatics·2026
Same journal

Clinician Perspectives on Ambient AI Scribes in the Intensive Care Unit: Qualitative Interview Study.

JMIR medical informatics·2026
Same journal

IdeaDistiller-AI Support for Idea Synthesis in Concept Mapping: Algorithm Development and Validation Study.

JMIR medical informatics·2026
Same journal

Pregnancy-Related Clinical Codes in Unlikely Populations in Primary Care.

JMIR medical informatics·2026
See all related articles

Related Experiment Video

Updated: Oct 8, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.1K

Text Mining of Adverse Events in Clinical Trials: Deep Learning Approach.

Daphne Chopard1, Matthias S Treder1, Padraig Corcoran1

  • 1School of Computer Science & Informatics, Cardiff University, Cardiff, United Kingdom.

JMIR Medical Informatics
|December 24, 2021
PubMed
Summary
This summary is machine-generated.

Automating adverse event coding in clinical trials is feasible. This method uses natural language processing to analyze reports, enabling faster identification of drug safety patterns and correlations.

Keywords:
classificationdeep learningmachine learningnatural language processing

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Related Experiment Videos

Last Updated: Oct 8, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.1K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Clinical Trial Monitoring
  • Medical Informatics

Background:

  • Pharmacovigilance is crucial for identifying unknown adverse events and pattern changes during medicine use.
  • Effective safety reporting is essential for drug development and patient well-being.

Purpose of the Study:

  • To demonstrate the feasibility of automating the coding of adverse events from narrative text in serious adverse event reports.
  • To enable statistical analysis of adverse event patterns for timely correlation with trial medications.

Main Methods:

  • Utilized the Unified Medical Language System (UMLS) for coding, integrating multiple terminologies.
  • Employed MetaMap for identifying UMLS concepts within report narratives.
  • Developed a Bidirectional Encoder Representations from Transformers (BERT) binary classifier to distinguish adverse events from other mentions.

Main Results:

  • The BERT model achieved a high F1 score of 0.8080, successfully handling class imbalance.
  • Performance was 10.15% lower than human performance but 17.45% higher than baseline methods.
  • Demonstrated the model's capability in accurately coding adverse events from unstructured text.

Conclusions:

  • Automated coding of adverse events in serious adverse event reports is feasible.
  • Statistical analysis of coded adverse events can reveal timely correlations with investigational medicines.
  • This approach enhances the efficiency of drug safety monitoring in clinical trials.